Top HIV researchers from amfAR are confirmed to present groundbreaking advancements in HIV cure research at the 13th International AIDS Society Conference on HIV Science (IAS 2025), to be held in Berlin. This year’s program highlights major progress in long-acting HIV treatments, AI-driven research, and global health funding concerns. The conference is a pivotal event amid rising anxiety over potential budget cuts to HIV programs globally.
Live Updates: Timeline of Events
-
July 10, 2025 | 10:30 AM IST – amfAR releases statement confirming participation in IAS 2025
-
July 10, 2025 | 10:45 AM IST – IAS 2025 preview shows focus on long-acting PrEP and AI in diagnostics
-
July 10, 2025 | 11:00 AM IST – amfAR scientist Dr. Rowena Johnston confirms presentation on gene-editing breakthroughs
-
July 10, 2025 | 11:15 AM IST – Global health advocates raise concerns about U.S. and EU budget reallocations
Official Confirmation and Sources
“This year’s IAS conference will spotlight the most promising technologies in HIV treatment and prevention,” said Dr. Rowena Johnston, amfAR’s Director of Research. “Our team is excited to share new data on gene-editing therapies and long-acting injectables.”
The International AIDS Society also confirmed via @iasociety that AI integration in diagnostics and treatment adherence monitoring will be core themes this year.
What’s the Impact?
-
For Patients: Expect potential shifts to bi-annual injectable PrEP and personalized AI-guided treatment regimens.
-
For Public Health: Potential game-changer in curbing HIV transmission rates, especially in low-access regions.
-
For Funding Programs: Activists warn that breakthroughs may be slowed by impending global health budget cuts.
Several advocacy groups, including UNAIDS and ACT UP, have urged governments to increase funding to ensure research translates into global availability.
Public and Social Media Reaction
The hashtag #IAS2025 began trending within hours of the amfAR announcement.
-
@HIVIreland tweeted:
“We’re on the cusp of a cure. Incredible work by @amfAR and global teams. Let’s ensure funding doesn’t fail the science. #IAS2025 #EndHIV”
-
@ACTUPNY posted:
“Don’t cut what’s working. We need action, not austerity. #HIVfunding #IAS2025”
Precautions and What to Do Now
No immediate public health threats are associated with this announcement. However:
-
If you’re living with HIV or on PrEP:
Consult your healthcare provider for updates on long-acting treatment availability in your region. -
Healthcare professionals and researchers:
Visit iasociety.org to register for IAS 2025 or access the pre-conference materials.
What Happens Next?
-
July 17–21, 2025 – IAS 2025 officially begins in Berlin
-
July 18, 2025 – amfAR's major presentation on CRISPR-based therapies
-
August 2025 – Expected release of updated global HIV treatment guidelines
Watch for announcements from WHO, NIH, and UNAIDS following the conference.
FAQs
🟠 What happened at IAS 2025?
Top researchers will present breakthroughs in HIV cure, prevention, and AI-aided diagnostics at the world’s premier HIV science conference.
🟠 Who is involved or affected?
Scientists, healthcare workers, patients, policymakers, and global health NGOs are all involved or impacted by the upcoming announcements.
🟠 Is it safe to travel to Berlin for IAS 2025?
Yes, Berlin is safe for travelers. Visit iasociety.org for official logistics.
🟠 How can I stay updated?
Follow @amfAR and @iasociety on Twitter or subscribe to IAS newsletters. Major presentations will be streamed live.
Final Summary – The Situation So Far
amfAR will present promising developments at IAS 2025, with a focus on HIV cures, long-acting treatments, and AI-powered care. While the science is advancing rapidly, funding instability remains a concern. The global health community awaits outcomes from the conference to guide future strategies